BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30488468)

  • 1. Reticulate acropigmentation of Kitamura with a novel mutation in ADAM10.
    Pan Y; Zhong W; Wang H; Yang Y; Lin Z
    Clin Exp Dermatol; 2019 Aug; 44(6):700-703. PubMed ID: 30488468
    [No Abstract]   [Full Text] [Related]  

  • 2. Reticulate acropigmentation of Kitamura with a novel ADAM10 mutation: A case report.
    Tsutsumi M; Kono M; Akiyama M; Katoh N; Nakai N
    J Dermatol; 2016 Aug; 43(8):963-5. PubMed ID: 26892935
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional implications of novel ADAM10 mutations in reticulate acropigmentation of Kitamura.
    Ralser DJ; Lestringant GG; Du-Thanh A; Kokordelis P; Fischer J; Basmanav FBÜ; Wolf S; Thiele H; Altmüller J; Nürnberg P; Oji V; Fritz G; Frank J; Betz RC
    Br J Dermatol; 2017 Dec; 177(6):e340-e343. PubMed ID: 29192958
    [No Abstract]   [Full Text] [Related]  

  • 4. Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: An update.
    Kono M; Akiyama M
    J Dermatol Sci; 2019 Feb; 93(2):75-81. PubMed ID: 30692041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease.
    Kono M; Sugiura K; Suganuma M; Hayashi M; Takama H; Suzuki T; Matsunaga K; Tomita Y; Akiyama M
    Hum Mol Genet; 2013 Sep; 22(17):3524-33. PubMed ID: 23666529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dowling-Degos disease with mutations in POFUT1 is clinicopathologically distinct from reticulate acropigmentation of Kitamura.
    Kono M; Suganuma M; Takama H; Zarzoso I; Saritha M; Bodet D; Aboobacker S; Kaliaperumal K; Suzuki T; Tomita Y; Sugiura K; Akiyama M
    Br J Dermatol; 2015 Aug; 173(2):584-6. PubMed ID: 25639155
    [No Abstract]   [Full Text] [Related]  

  • 7. A new nonsense mutation in the POGLUT1 gene in two sisters with Dowling-Degos disease.
    Duchatelet S; Clerc H; Machet L; Gaboriaud P; Miskinyte S; Kervarrec T; Hovnanian A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):e440-e442. PubMed ID: 29569780
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura.
    Okamura K; Abe Y; Araki Y; Hozumi Y; Kawaguchi M; Suzuki T
    Pigment Cell Melanoma Res; 2016 Mar; 29(2):243-6. PubMed ID: 26708207
    [No Abstract]   [Full Text] [Related]  

  • 9. Vulvar Dyschromia in a Child: A Quiz.
    de Lorenzi C; Kaya G; Quenan S; Calza AM
    Acta Derm Venereol; 2019 Jun; 99(7):711-712. PubMed ID: 30938832
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dowling-Degos syndrome].
    Castellanos-González M; García Martos M; Segurado MA
    Med Clin (Barc); 2015 Jul; 145(1):e1. PubMed ID: 25659864
    [No Abstract]   [Full Text] [Related]  

  • 11. Dowling-Degos disease associated with hidradenitis suppurativa: a case report.
    Arjona-Aguilera C; Linares-Barrios M; Albarrán-Planelles C; Jiménez-Gallo D
    Actas Dermosifiliogr; 2015 May; 106(4):337-8. PubMed ID: 25529465
    [No Abstract]   [Full Text] [Related]  

  • 12. Vesicular variant of Dowling-Degos disease.
    Linke M; Orouji A; Géraud C
    Br J Dermatol; 2018 Sep; 179(3):795-796. PubMed ID: 29931677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hereditary pigmentary disorders: light from the East].
    Dereure O
    Ann Dermatol Venereol; 2014 Jan; 141(1):77-8. PubMed ID: 24461102
    [No Abstract]   [Full Text] [Related]  

  • 14. Comorbidities or different entities? Phenotype variability associated with PSENEN mutations.
    Li W; Xu H; He Y; Lin L; Li C
    Br J Dermatol; 2019 Jan; 180(1):221-222. PubMed ID: 30144026
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenicity of POFUT1 in Dowling-Degos disease: additional mutations and clinical overlap with reticulate acropigmentation of kitamura.
    Buket Basmanav F; Fritz G; Lestringant GG; Pachat D; Hoffjan S; Fischer J; Wehner M; Wolf S; Thiele H; Altmüller J; Pulimood SA; Rütten A; Kruse R; Hanneken S; Frank J; Danda S; Bygum A; Betz RC
    J Invest Dermatol; 2015 Feb; 135(2):615-618. PubMed ID: 25229252
    [No Abstract]   [Full Text] [Related]  

  • 16. An uncommon presentation of Galli-Galli disease.
    Desai CA; Virmani N; Sakhiya J; Khopkar U
    Indian J Dermatol Venereol Leprol; 2016; 82(6):720-723. PubMed ID: 27643541
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease.
    Wilson NJ; Cole C; Kroboth K; Hunter WN; Mann JA; McLean WH; Kernland Lang K; Beltraminelli H; Sabroe RA; Tiffin N; Sobey GJ; Borradori L; Simpson E; Smith FJ
    Br J Dermatol; 2017 Jan; 176(1):270-274. PubMed ID: 27479915
    [No Abstract]   [Full Text] [Related]  

  • 18. The spectrum of reticulate pigment disorders of the skin revisited.
    Müller CS; Tremezaygues L; Pföhler C; Vogt T
    Eur J Dermatol; 2012; 22(5):596-604. PubMed ID: 23018017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated review of genetic reticulate pigmentary disorders.
    Zhang J; Li M; Yao Z
    Br J Dermatol; 2017 Oct; 177(4):945-959. PubMed ID: 28407215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulate acropigmentation of Kitamura.
    Das A; Das D; Ghosh A
    Indian Pediatr; 2013 Oct; 50(10):980-1. PubMed ID: 24222296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.